• Loading stock data...
Est. 2004

Sunday 02/17/2019

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More


  • 2:09 PM

    REDONDO BEACH, CA–(Marketwired – Jan 31, 2017) – SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication of an article discussing AXIM® Biotechnologies Inc.’s (OTCQB: AXIM) efforts to keep its drug development costs at a minimum. The average cost of developing a prescription drug is some $2.6 billion, according to the Tufts Center for the Study of Drug Development, which includes $1.4 billion in out-of-pocket costs and an estimated $1.2

    Read more
  • 1:44 PM

    AXIM Biotechnologies Announces Positive Pharmacokinetic (PK) Data Results on Proprietary Delivery Method for Cannabinoids in Chewing Gum SAN DIEGO, CA —  AXIM, (Marketwired) —  Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech)(OTC: AXIM) has received positive pharmacokinetic (PK) data results on its CanChew Plus® CBD Gum, which will be used in upcoming clinical trials with patients suffering from irritable bowel

    Read more
  • 3:35 PM

    BOULDER, Colo., Mar 05, 2015 (BUSINESS WIRE) — First Opportunity Fund, Inc. (OTC: FOFI) (the “Fund”) announced that earlier today its board of directors declared a dividend for the Fund in connection with the reorganization of the Fund, Boulder Total Return Fund, Inc. and The Denali Fund Inc. into Boulder Growth & Income Fund, Inc. (“BIF”), with BIF continuing as the surviving fund (the “Reorganization”). The Fund declared a dividend of $0.075 per common share payable in cash on March 19,

    Read more
Public Wire Banner